Greenbrook TMS Inc. (GBNH)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:40AM EST. Market open.
Sign in to post a message.
- Y
GTMS.TO reached a 52 Week low at 5.75 - YGTMS.TO is down 11.13% to 5.75
- YGTMS.TO reached a 52 Week low at 6.91
- YGTMS.TO is up 7.14% to 7.50
- YGTMS.TO reached a 52 Week low at 6.44
- YGTMS.TO is down 8.58% to 7.25
- YGTMS.TO is up 9.16% to 9.06
- YGTMS.TO is down 7.98% to 9.00
- YGTMS.TO is up 6.77% to 9.62
- G
anyone holding this stock ?? - B
Buy indicator at 1.60 points and currently undervalued. very strong bullish evidence for short and long term. projections are at $3.50 to $4.50. Any thoughts? - C
what is this? Why this is unactive? - E
with 120 treatment centers in US and the addition of Spravato pilot program as a driver for revenue I am imagining some serious upside. Guess the traders are waiting on Nasdaq. Future use of psiloycybin and a further broadening of revenue stream. What's not to like?? GLTA - W
great company lets go!! - R
400% up is thrilling - YGTMS.TO is up 7.77% to 2.08
- O
Like the stock. It is the best way to play TMS for depression. The equipment market is highly competitive. In the service provider, they have about 10% of the working machines, but a much higher portion of treatments as many of the machines are in solo practice offices that get little use. (When was the last time your local psychiatrist was a great business person?) Challenge is liquidity. An equity raise would be good for the company and shareholders. Hopefully they will raise $40 million sooner rather than later. - YGTMS.TO is up 11.43% to 2.73
- ONeuronetics reported 15% procedure growth this quarter on their devices. GBNH is the largest provider of TMS for depression. So the read through is encouraging.
- YGTMS.TO reached a 52 Week high at 2.87
